A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Avita Medical, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 19,800 shares of RCEL stock, worth $191,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,800
Previous 19,300 2.59%
Holding current value
$191,466
Previous $264,000 20.08%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$12.56 - $18.31 $180,449 - $263,059
14,367 Added 427.21%
17,730 $284,000
Q4 2023

Feb 14, 2024

SELL
$9.29 - $14.57 $127,904 - $200,599
-13,768 Reduced 80.37%
3,363 $46,000
Q3 2023

Nov 14, 2023

BUY
$13.84 - $20.79 $174,328 - $261,870
12,596 Added 277.75%
17,131 $250,000
Q2 2023

Aug 14, 2023

SELL
$10.7 - $17.48 $1.11 Million - $1.82 Million
-104,204 Reduced 95.83%
4,535 $77,000
Q1 2023

May 15, 2023

BUY
$6.45 - $14.48 $428,970 - $963,021
66,507 Added 157.48%
108,739 $1.52 Million
Q4 2022

Feb 14, 2023

BUY
$4.66 - $7.55 $77,919 - $126,243
16,721 Added 65.54%
42,232 $278,000
Q3 2022

Nov 14, 2022

SELL
$4.97 - $7.89 $306,291 - $486,244
-61,628 Reduced 70.72%
25,511 $135,000
Q2 2022

Aug 15, 2022

BUY
$4.6 - $8.82 $338,150 - $648,367
73,511 Added 539.41%
87,139 $414,000
Q4 2021

Feb 14, 2022

SELL
$11.72 - $19.66 $503,186 - $844,082
-42,934 Reduced 75.91%
13,628 $163,000
Q1 2021

May 17, 2021

BUY
$18.38 - $28.41 $465,087 - $718,886
25,304 Added 80.95%
56,562 $1.12 Million
Q4 2020

Feb 16, 2021

BUY
$17.55 - $27.2 $169,533 - $262,752
9,660 Added 44.73%
31,258 $581,000
Q3 2020

Nov 16, 2020

BUY
$20.83 - $30.0 $449,886 - $647,940
21,598 New
21,598 $544,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $242M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.